You are here: Industry Insights > Market News > Japan Health Ministry finds new coronavirus variant

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

Japan Health Ministry finds new coronavirus variant

expresspharmaJanuary 12, 2021

Tag: coronavirus , variant , virus , Japan

Favorites

The Health Ministry of Japan has found a COVID-19 variant in people arriving from Brazil that’s different from the ones in Britain and South Africa.

The variant was identified in airport tests on a man in his 40s, a woman in her 30s and two teens, the ministry said.

Japan is working with other nations, the WHO and other medical experts to analyse the new version of the virus. It is not clear whether the current vaccines will be effective against the new variant.

About 30 cases of variants from Britain and South Africa have earlier been reported in Japan. Experts are worried the variants appear to spread faster.

Previous:Dr Reddy’s Laboratories launches Febuxostat Tablets in US

Next:JB Chemicals gets ANDA approval from US FDA for Loratadine Tablets

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Japan Health Ministry finds new coronavirus variant | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Recombinant Human Brain-Derived Neurotrophic Factor, variant 3

Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)

Recombinant Rat Brain-Derived Neurotrophic Factor, variant 4

double virus inactivation Human Immunoglobulin (pH4) for Intravenous Injection

FiltraLinX® Virus Filter Holder

Gallic acid Japanese enterprise standard

Recombinant Rat Brain-Derived Neurotrophic Factor, variant 1

Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Organic Matcha Tea Powder

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine

Virus Related Peptides

Japan Health Ministry finds new coronavirus variant

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>